SE0302559D0 - Method - Google Patents

Method

Info

Publication number
SE0302559D0
SE0302559D0 SE0302559A SE0302559A SE0302559D0 SE 0302559 D0 SE0302559 D0 SE 0302559D0 SE 0302559 A SE0302559 A SE 0302559A SE 0302559 A SE0302559 A SE 0302559A SE 0302559 D0 SE0302559 D0 SE 0302559D0
Authority
SE
Sweden
Prior art keywords
methods
specific drug
disease
mmp12
copd
Prior art date
Application number
SE0302559A
Other languages
English (en)
Swedish (sv)
Inventor
Thomas Fehniger
Gyoergy Marko-Varga
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0302559A priority Critical patent/SE0302559D0/xx
Publication of SE0302559D0 publication Critical patent/SE0302559D0/xx
Priority to US10/572,872 priority patent/US8012692B2/en
Priority to PCT/SE2004/001378 priority patent/WO2005029090A1/en
Priority to AT04775479T priority patent/ATE393395T1/de
Priority to EP04775479A priority patent/EP1668372B1/en
Priority to DE602004013350T priority patent/DE602004013350T2/de
Priority to ES04775479T priority patent/ES2303954T3/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6884—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from lung
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/12—Pulmonary diseases
    • G01N2800/122—Chronic or obstructive airway disorders, e.g. asthma COPD
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
SE0302559A 2003-09-25 2003-09-25 Method SE0302559D0 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE0302559A SE0302559D0 (sv) 2003-09-25 2003-09-25 Method
US10/572,872 US8012692B2 (en) 2003-09-25 2004-09-24 Elastin peptide fingerprints and analysis methods for MMP12 related to COPD
PCT/SE2004/001378 WO2005029090A1 (en) 2003-09-25 2004-09-24 Elastin peptide fingerprints and analysis methods for mmp12 related to copd
AT04775479T ATE393395T1 (de) 2003-09-25 2004-09-24 Elastinpeptid-fingerabdrücke und analyseverfahren für mit copd in verbindung stehendes mmp12
EP04775479A EP1668372B1 (en) 2003-09-25 2004-09-24 Elastin peptide fingerprints and analysis methods for mmp12 related to copd
DE602004013350T DE602004013350T2 (de) 2003-09-25 2004-09-24 Elastinpeptid-fingerabdrücke und analyseverfahren für mit copd in verbindung stehendes mmp12
ES04775479T ES2303954T3 (es) 2003-09-25 2004-09-24 Huellas peptidicas de elastina y metodos de analisis para mmp12 relacionadas con copd.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0302559A SE0302559D0 (sv) 2003-09-25 2003-09-25 Method

Publications (1)

Publication Number Publication Date
SE0302559D0 true SE0302559D0 (sv) 2003-09-25

Family

ID=29246968

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0302559A SE0302559D0 (sv) 2003-09-25 2003-09-25 Method

Country Status (7)

Country Link
US (1) US8012692B2 (xx)
EP (1) EP1668372B1 (xx)
AT (1) ATE393395T1 (xx)
DE (1) DE602004013350T2 (xx)
ES (1) ES2303954T3 (xx)
SE (1) SE0302559D0 (xx)
WO (1) WO2005029090A1 (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100203565A1 (en) * 2005-03-22 2010-08-12 Astrazeneca Ab Peptide Fingerprint from the Degradation of Elastin by HNE
CA3026701C (en) 2009-03-02 2023-04-18 Massachusetts Institute Of Technology Methods and products for in vivo enzyme profiling
EP2686000B1 (en) 2011-03-15 2021-05-05 Massachusetts Institute of Technology Multiplexed detection with isotope-coded reporters
SG11201508199QA (en) * 2013-04-05 2015-11-27 Claudia Zylberberg Matrix metalloproteinases and uses thereof
CN118010994A (zh) 2013-06-07 2024-05-10 麻省理工学院 基于亲和力检测配体编码的合成性生物标记物
CN105527361B (zh) * 2014-09-29 2017-06-20 上海市计算技术研究所 一种高效微流电色谱相似度分析以及计算影响度的方法
EP3440013A4 (en) 2016-04-08 2021-03-17 Massachusetts Institute of Technology METHOD FOR SPECIFIC PROFILING OF PROTEASE ACTIVITY ON LYMPH NODES
CA3022928A1 (en) 2016-05-05 2017-11-09 Massachusetts Institute Of Technology Methods and uses for remotely triggered protease activity measurements
AU2018248327B2 (en) 2017-04-07 2024-10-10 Massachusetts Institute Of Technology Methods to spatially profile protease activity in tissue and sections
GB201802070D0 (en) * 2018-02-08 2018-03-28 Nordic Bioscience As Elastin assay
WO2019173332A1 (en) 2018-03-05 2019-09-12 Massachusetts Institute Of Technology Inhalable nanosensors with volatile reporters and uses thereof
CN108872442B (zh) * 2018-08-17 2021-04-27 无限极（中国）有限公司 一种基于谱效关系的骨胶原肽质量检测方法
EP3911753A1 (en) 2019-01-17 2021-11-24 Massachusetts Institute of Technology Sensors for detecting and imaging of cancer metastasis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989001625A1 (en) * 1987-08-07 1989-02-23 Graduate Hospital Foundation Research Corporation Immunologic identification of carboxy terminal sequences of elastin in human plasma using monospecific antibodies
US6124107A (en) * 1988-06-10 2000-09-26 Merck & Co., Inc. Assay for marker of human polymorphonuclear leukocyte elastase activity
AU8088191A (en) * 1990-05-11 1991-12-10 Graduate Hospital Foundation Research Corporation Immunoassay of elastin peptides in urine
CA2330929A1 (en) 1998-06-06 1999-12-16 Genostic Pharma Limited Probes used for genetic profiling
US6797523B2 (en) * 2000-11-30 2004-09-28 Affinium Pharmaceuticals, Inc. Methods for systematic identification of protein—protein interactions
WO2002050287A2 (en) * 2000-12-18 2002-06-27 Arriva Pharmaceuticals, Inc. Multifunctional protease inhibitors and their use in treatment of disease

Also Published As

Publication number Publication date
EP1668372A1 (en) 2006-06-14
US8012692B2 (en) 2011-09-06
WO2005029090A1 (en) 2005-03-31
EP1668372B1 (en) 2008-04-23
US20060292631A1 (en) 2006-12-28
DE602004013350T2 (de) 2009-05-20
DE602004013350D1 (de) 2008-06-05
ATE393395T1 (de) 2008-05-15
ES2303954T3 (es) 2008-09-01

Similar Documents

Publication Publication Date Title
SE0302559D0 (sv) Method
WO2003000842A3 (en) Novel proteins and nucleic acids encoding same
ATE382053T1 (de) System zur antikörperexpression und- synthese
WO2007097923A3 (en) Method of constructing and screening libraries of peptide structures
DE60335000D1 (de) In vitro peptid-expressionsbank
GEP20105059B (en) Anti-cd154 antibodies
MY171913A (en) Methods for determining ligand binding to a target protein using a thermal shift assay
JP2019507341A5 (xx)
EA200801174A1 (ru) Антитела-миметики glp-2, полипептиды, композиции, способы и применения
ATE463512T1 (de) Identifizierung und charakterisierung von funktionsblockierenden anti-ed-b-fibronektin antikörpern
WO2007039256A3 (de) Bindungsdomänen von proteinen der repulsive guidance molecule (rgm) proteinfamilie und funktionale fragmente davon sowie deren verwendung
EA201170762A1 (ru) Способы отбора устойчивых к протеазе полипептидов
WO2004024750A3 (en) Cd44-binding ligands
WO2004029072A3 (en) PrPsc -INTERACTING MOLECULES AND USES THEREOF
CA2735138C (en) Screening methods for transfusion related acute lung injury (trali)
WO2020198264A8 (en) Modified cleavases, uses thereof and related kits
WO2002081498A3 (en) Novel proteins and nucleic acids encoding same
WO2005084193A3 (en) Method for identifying a site of protein-protein interaction for the rational design of short peptides that interfere with that interaction
WO2009074318A3 (en) Novel rubella e1 envelope protein variants and their use in the detection of anti-rubella antibodies
WO2003010327A3 (en) Novel proteins and nucleic acids encoding same
WO2005042006A3 (en) Use of ephrins and related molecules to regulate cellular proliferation
WO2008142664A3 (en) Exposed thymidine kinase 1 peptides, ligands and methods employing the same
WO2004042083A3 (en) Nucleic acid ligands and uses therefor
GB2441937A (en) Antibodies for anthrax
Martiáñez-Vendrell et al. Proteomics approaches for the identification of protease substrates during virus infection